Jason Russell
Analyst
Morgan Stanley
Equibles does not estimate personal net worth.
About Jason Russell
Jason Russell is recorded as Analyst at Morgan Stanley. Jason Russell has spoken on 3 investor events across 3 companies, most recently for MBX Biosciences, Inc. on September 16, 2026. Those appearances were for MBX Biosciences, Inc. (MBX), Faeth Therapeutics, Inc. (FTH) and Biocryst Pharmaceuticals Inc (BCRX). The companies whose calls Jason Russell spoke on are classified in the Healthcare sector.
Jason Russell on recent calls
“We're saving the best for last here at the Morgan Stanley Conference. I'm Jason Russell, and it's a pleasure to welcome MBX to the stage, so CEO Steve Herter, as well as Dr. Sam Azoulay, who is the chief medical officer.”
“Thank you, everyone, for joining here for the third day of the Morgan Stanley Healthcare Conference. My name is Jason Russell. I'm Managing Director with the team.”
“It's a pleasure to welcome Charlie Gehr here from Biocrist, the, quote, newly appointed CEO of Biocrist. I think he took the job on January 1st of this year. We're excited to have Biocrist here.”
Affiliation history
-
Morgan Stanley
Analyst
Transcript header (unverified)
Current
Company network
Drug Manufacturers - Specialty & Generic · Healthcare
1 appearance
Latest appearance 2026-09-15
View calls and events